Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/1259
Middle east respiratory syndrome coronavirus (MERS-COV): A review
Ramadan, N
Shaib, H
Acceso Abierto
Atribución-NoComercial-SinDerivadas
As a novel coronavirus first reported by Saudi Arabia in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) is responsible for an acute human respiratory syndrome. The virus, of 2C beta-CoV lineage, expresses the dipeptidyl peptidase 4 (DPP4) receptor and is densely endemic in dromedary camels of East Africa and the Arabian Peninsula. MERS-CoV is zoonotic but human-to-human transmission is also possible. Surveillance and phylogenetic researches indicate MERS-CoV to be closely associated with bats' coronaviruses, suggesting bats as reservoirs, although unconfirmed. With no vaccine currently available for MERS-CoV nor approved prophylactics, its global spread to over 25 countries with high fatalities highlights its role as ongoing public health threat. An articulated action plan ought to be taken, preferably from a One Health perspective, for appropriately advanced countermeasures against MERS-CoV.
Germs
2019
Preimpreso
https://coronavirus.1science.com/item/c8083f73ab34303aaa01fa83d8758b075235a208
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
107121.pdf280.29 kBAdobe PDFView/Open